Skip to Content

Popular

Having trouble identifying your medications? Try the Pill Identifier

Quickly identify pills, tablets and capsules using the web's most comprehensive Pill Identification Wizard.

Get Started

Featured Tool

Worried about drug interactions? Use the Interactions Checker

The drug interactions tool allows you to check for drug-drug and drug-food interactions.

Check Now

Featured Tool

Discover treatment options with the new Symptom Checker

This interactive decision guide helps identify the underlying cause of common symptoms.

Get Started

Featured Tool

Custom search for Medical Transcriptionists?

Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.

Get Started

Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.

Posted today in Pharma Industry News

Monthly News Roundup - June 2015

FDA Approves Antiplatelet Agent Kengreal The U.S. Food and Drug Administration has approved The Medicines Company’s Kengreal (cangrelor), an intravenous blood thinner (P2Y12 platelet inhibitor) used in patients undergoing Percutaneous Coronary Intervention (PCI) to reduce the risk of thrombotic events, like heart attack or stent thrombosis, during...

Posted today in Medical

Americans Want Online Access to Doctors, Health Records: Survey

Internet-savvy Americans would like to add their doctors to their group of Facebook "friends" or email contacts. In a new study, researchers analyzed more than 2,250 responses from a national survey of retail pharmacy customers. Many of those surveyed were frequent Facebook users who wanted to be able to contact their doctor about health-related matters...

Posted today in Clinical Trials

MediciNova Announces the Completion of Enrollment in Clinical Trial of MN-166 (ibudilast) in Alcohol Dependence

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that the clinical trial of MN-166 (ibudilast) in alcohol dependence has completed enrollment of 24 subjects. Yuichi Iwaki, MD, PhD, President and Chief Executive Officer...

Posted yesterday in Clinical Trials

Juno Announces FDA Acceptance of Investigational NDA for JCAR017 in Relapsed/Refractory B Cell Non-Hodgkin Lymphoma

Juno Therapeutics, Inc. (Nasdaq:JUNO), a biopharmaceutical company focused on re-engaging the body's immune system to revolutionize the treatment of cancer, today announced the U.S. Food and Drug Administration (FDA) accepted the Company's investigational new drug (IND) application for JCAR017 for patients with relapsed/refractory (r/r) B cell non-Hodgkin...

Posted today in Medical

Most U.S. Hepatitis C Infections May Be Missed: Study

New cases of hepatitis C are drastically underreported to federal officials, researchers contend in a new study. And they suggested that may be hampering public health efforts to cope with the chronic infection that can lead to cirrhosis or liver cancer. The new study found that only one out of 183 Massachusetts residents diagnosed between 2001 and...

Posted today in Medical

White Men May Get Better Treatment for Abnormal Heartbeat

Women, Hispanics and blacks are less likely than white men to receive optimal treatment for atrial fibrillation in the United States, researchers say. The study of more than a half-million Medicare patients found that women with this abnormal heart rhythm are less likely than men to get blood thinners to prevent stroke, which is a serious risk with...

Posted today in Medical

Make CPR, Defibrillator Training Mandatory for High School Graduation: Experts

Far too few Americans are surviving cardiac arrest, and a new report issued Tuesday by a federally appointed panel of experts sets out ways to boost survival rates. One recommendation: Make a working knowledge of CPR and the use of an automated electronic defibrillator (AED) a graduation requirement for all middle- and high-school students. One expert...

Posted today in Medical

Too Few Men With Low-Risk Prostate Cancers Get 'Watch and Wait' Approach

A wide majority of U.S. men with low-risk prostate cancer are being treated for the disease even though "active surveillance" is an option, a new report finds. Active surveillance -- or watchful waiting -- is the careful monitoring of prostate cancer for progression of the cancer that would indicate a need for treatment. Men in the Northeast and on...

Posted today in Medical

Under-the-Tongue Hay Fever Pills Offer Little Benefit: Study

Under-the-tongue pills for hay fever sufferers provide little symptom relief and often come with bothersome side effects, new research finds. Under-the-tongue, or sublingual, therapy is widely used in Europe as an alternative to allergy shots. In the United States, two such "immunotherapy" pills have been approved recently by the U.S. Food and Drug...

Posted today in Medical

Umbilical Cord 'Milking' May Help Preemies Delivered by C-Section

Gently massaging the umbilical cords of preterm infants delivered by C-section may improve their blood pressure, boost blood flow and increase levels of red blood cells, a new study finds. Researchers suggest this technique could offer these preemies greater health benefits than the current method of delaying cord clamping for up to one minute after...

Read more news...

Recently added consumer and prescribing information: Viberzi, Stiolto Respimat, Kybella, Corlanor, Cresemba, Zarxio, Farydak, Lenvima, Ibrance, Glyxambi

Posted in Blog

Drug Shortages: Has the FDA Response Made an Impact?

Rationing of much needed medications for patients is a scary thought for me as a healthcare professional. I can understand when an orphan drug may go in short supply for a rare disease, but when commonly used medications like antibiotics and intravenous fluids become scarce, I wonder what the forces are that cause this to […]

Posted in Blog

Harnessing the Power of the Poliovirus as a Cancer Cure

Polio, a highly infectious and crippling disease, was certainly one of the most feared viruses in the 20th century. Each year, thousands of children were left paralyzed. Polio has been successfully eliminated in the U.S. for decades due to a widespread vaccine program. So why would a group of researchers be interested in injecting the […]

Posted in Blog

Biosimilars in 2015: What Can We Expect?

On Friday, March 6th, 2015 the FDA approved Sandoz’s Zarxio, the first official biosimilar that will be made available in the U.S. Zarxio, a recombinant granulocyte colony-stimulating factor used to boost white blood cells after cancer treatments, is the long-awaited biosimilar for filgrastim (Amgen’s Neupogen). The FDA noted in their briefs that Zarxio was “highly […]

See more blog posts or follow us on twitter.

(web1)